Niagen Bioscience, Inc. (NAGE)
6.59
+0.08
(+1.23%)
USD |
NASDAQ |
Dec 10, 16:00
6.59
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Market Cap: 525.92M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| TransMedics Group, Inc. | 4.484B |
| Liquidia Corp. | 2.843B |
| Recursion Pharmaceuticals, Inc. | 2.483B |
| Caris Life Sciences, Inc. | 7.622B |
| CEL-SCI Corp. | 19.82M |
Market Cap Related Metrics
| PE Ratio | 27.09 |
| PS Ratio | 4.462 |
| PEG Ratio | 0.0229 |
| Price to Book Value | 7.441 |
| Price to Free Cash Flow | 26.38 |
| Price | 6.59 |
| Earnings Yield | 3.69% |
| PEGY Ratio | 0.0229 |
| Operating PE Ratio | 28.83 |
| Normalized PE Ratio | 27.07 |